Glutamyl aminopeptidase

Glutamyl aminopeptidase, also known as aminopeptidase A (APA), is an enzyme that plays a crucial role in the metabolism of peptides by catalyzing the cleavage of N-terminal glutamyl residues from peptide substrates. This enzyme is a member of the M1 family of metallopeptidases and is encoded by the ENPEP gene in humans.

Structure

Glutamyl aminopeptidase is a type II membrane-bound glycoprotein. It consists of a short N-terminal cytoplasmic domain, a single transmembrane domain, and a large extracellular domain that contains the active site. The enzyme requires zinc as a cofactor for its catalytic activity, which is characteristic of metallopeptidases.

Function

The primary function of glutamyl aminopeptidase is to regulate the activity of peptide hormones and neuropeptides by removing glutamyl residues from their N-terminus. This activity is important in the renin-angiotensin system, where it converts angiotensin II to angiotensin III, thereby modulating blood pressure and electrolyte balance.

Clinical Significance

Glutamyl aminopeptidase has been implicated in various physiological and pathological processes. Its role in the renin-angiotensin system makes it a potential target for the treatment of hypertension and heart failure. Additionally, altered expression of this enzyme has been observed in certain types of cancer, suggesting a role in tumor progression and metastasis.

Research and Therapeutic Potential

Research into glutamyl aminopeptidase is ongoing, with studies focusing on its potential as a therapeutic target. Inhibitors of this enzyme are being investigated for their ability to modulate blood pressure and for their potential anti-cancer properties.

See Also

• Aminopeptidase
• Renin-angiotensin system
• Metallopeptidase

External Links

• UniProt entry for Glutamyl Aminopeptidase
• NCBI Gene entry for ENPEP